Share of Clicks for top 10 US Pharma & Biotech Research and Development brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| lilly.com | 22.23 |
| pfizerforall.com | 9.55 |
| jnj.com | 9.37 |
| abbvie.com | 7.23 |
| gsk.com | 5.19 |
| sequencing.com | 4.12 |
| bms.com | 3.22 |
| evenity.com | 1.64 |
| myriad.com | 1.63 |
| regeneron.com | 1.54 |
| others | 34.28 |
- lilly.com - 22.23%
- pfizerforall.com - 9.55%
- jnj.com - 9.37%
- abbvie.com - 7.23%
- gsk.com - 5.19%
- sequencing.com - 4.12%
- bms.com - 3.22%
- evenity.com - 1.64%
- myriad.com - 1.63%
- regeneron.com - 1.54%
- others - 34.28%
Copyright © Adthena. All rights reserved.
In the PPC landscape, Lilly leads with 22.23% click share, followed by Pfizerforall at 9.55%. Others collectively hold 34.28%, showcasing diverse competition.
Share of Spend for the top 10 US Pharma & Biotech Research and Development brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | lilly.com | pfizerforall.com | jnj.com | myriad.com | tecvayli.com | gsk.com | abbvie.com | maximustribe.com | evenity.com | ivyrx.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/02/01 | 9.21% | 25.51% | 0.02% | 3.27% | 4.19% | 2.18% | 1.73% | 1.36% | 4.09% | 2.56% |
| 2026/02/02 | 3.72% | 15.43% | 0.9% | 3.09% | 1.98% | 2.08% | 1.66% | 0.5% | 7.43% | 2.79% |
| 2026/02/03 | 4.44% | 15.6% | 0.2% | 3.69% | 1.21% | 1.2% | 2.03% | 4.9% | 3.85% | 3.2% |
| 2026/02/04 | 10.65% | 10.31% | 7.26% | 2.01% | 2.52% | 0.86% | 2.03% | 2.2% | 2.61% | 1.62% |
| 2026/02/05 | 7.92% | 9.27% | 7.81% | 2.55% | 2.27% | 0.87% | 0.24% | 4.12% | 5.41% | 2.96% |
| 2026/02/06 | 11.58% | 17.62% | 8.4% | 2.46% | 1.34% | 1.13% | 1.27% | 0.88% | 5.56% | 4.08% |
| 2026/02/07 | 21.17% | 10.12% | 6.43% | 1.46% | 1.98% | 1.18% | 2.45% | 1.55% | 5.98% | 3.71% |
| 2026/02/08 | 10.1% | 27.85% | 0.03% | 2.68% | 2.47% | 2.43% | 2.85% | 0.98% | 2.6% | 2.76% |
| 2026/02/09 | 8.83% | 25.95% | 0.08% | 1.88% | 2.49% | 1.64% | 2.23% | 1.1% | 4.92% | 3.65% |
| 2026/02/10 | 8.4% | 29.42% | 0.03% | 1.64% | 1.53% | 1.85% | 0.91% | 2.33% | 5.21% | 2.52% |
| 2026/02/11 | 14.59% | 29.13% | 2.57% | 1.43% | 1.29% | 1.83% | 0.94% | 2.12% | 3.66% | 1.88% |
| 2026/02/12 | 7.89% | 9.23% | 7.77% | 2.54% | 2.26% | 0.87% | 0.24% | 4.1% | 5.38% | 2.94% |
| 2026/02/13 | 11.55% | 17.63% | 8.37% | 2.45% | 1.34% | 1.12% | 1.26% | 0.88% | 5.54% | 4.07% |
| 2026/02/14 | 21.02% | 10.05% | 6.38% | 1.45% | 1.96% | 1.21% | 2.43% | 1.54% | 5.93% | 3.68% |
| 2026/02/15 | 10.01% | 27.61% | 0.09% | 2.66% | 2.45% | 2.41% | 2.83% | 0.97% | 2.57% | 2.74% |
| 2026/02/16 | 8.8% | 25.87% | 0.08% | 1.88% | 2.48% | 1.64% | 2.23% | 1.09% | 4.9% | 3.64% |
| 2026/02/17 | 20.73% | 19.81% | 0.01% | 1.43% | 0.92% | 0.5% | 1.18% | 0% | 4.1% | 0.5% |
| 2026/02/18 | 20.55% | 22.67% | 5.32% | 1.82% | 1.24% | 1.55% | 1.31% | 1.03% | 1.57% | 0.64% |
| 2026/02/19 | 30.26% | 19.39% | 5.8% | 1.18% | 0.67% | 1.79% | 1.51% | 2.01% | 1.74% | 1.52% |
| 2026/02/20 | 32.94% | 22.19% | 3.93% | 1.64% | 1.16% | 1.05% | 1.14% | 2.03% | 2.69% | 1.14% |
| 2026/02/21 | 34.97% | 18.39% | 5.84% | 1.88% | 2.73% | 1.42% | 3.02% | 0.93% | 1.77% | 1.2% |
| 2026/02/22 | 27.65% | 19.32% | 0.06% | 2.86% | 1.66% | 1.77% | 4.73% | 1.76% | 3.12% | 0.94% |
| 2026/02/23 | 18.22% | 25.54% | 0% | 2.74% | 1.93% | 1.24% | 0.94% | 4.99% | 3.24% | 1.73% |
| 2026/02/24 | 22.46% | 29.36% | 0.08% | 2.97% | 1.32% | 1.38% | 0.53% | 0.56% | 1.61% | 1.24% |
| 2026/02/25 | 17.92% | 27.67% | 6.15% | 1.51% | 1.23% | 1.11% | 2.81% | 0.9% | 2.41% | 2.18% |
| 2026/02/26 | 19.2% | 25.36% | 7.9% | 3.2% | 1.58% | 1.39% | 1.38% | 1.36% | 1.83% | 1.86% |
| 2026/02/27 | 37.08% | 17.1% | 6.42% | 2.42% | 0.84% | 1.32% | 0.49% | 1.57% | 2.76% | 1.96% |
| 2026/02/28 | 32.1% | 15.52% | 4.75% | 3.34% | 3.25% | 3.12% | 2.82% | 1.14% | 1.09% | 0.47% |
- lilly.com
- pfizerforall.com
- jnj.com
- myriad.com
- tecvayli.com
- gsk.com
- abbvie.com
- maximustribe.com
- evenity.com
- ivyrx.com
Copyright © Adthena. All rights reserved.
Lilly.com surged mid-month, peaking at 37.08 on February 27. Pfizerforall.com fluctuated, ending at 15.52. Jnj.com remained low, while Myriad.com and Tecvayli.com showed modest gains. February closed with diverse trends.
Competitor Count for US Pharma & Biotech Research and Development
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/02/01 | 492 |
| 2026/02/02 | 508 |
| 2026/02/03 | 500 |
| 2026/02/04 | 491 |
| 2026/02/05 | 496 |
| 2026/02/06 | 487 |
| 2026/02/07 | 477 |
| 2026/02/08 | 484 |
| 2026/02/09 | 498 |
| 2026/02/10 | 488 |
| 2026/02/11 | 487 |
| 2026/02/12 | 496 |
| 2026/02/13 | 487 |
| 2026/02/14 | 477 |
| 2026/02/15 | 484 |
| 2026/02/16 | 498 |
| 2026/02/17 | 467 |
| 2026/02/18 | 480 |
| 2026/02/19 | 486 |
| 2026/02/20 | 464 |
| 2026/02/21 | 455 |
| 2026/02/22 | 477 |
| 2026/02/23 | 499 |
| 2026/02/24 | 479 |
| 2026/02/25 | 458 |
| 2026/02/26 | 451 |
| 2026/02/27 | 440 |
| 2026/02/28 | 426 |
Copyright © Adthena. All rights reserved.
February saw a dynamic shift in distinct advertisers, starting at 492 and peaking at 508. A gradual decline followed, ending the month at 426.
